We are live on ! Find out more
ST

Skorpios Trust Portfolio holdings

AUM $53.2M
1-Year Est. Return 90.96%
This Fund
S&P 500
This Quarter Est. Return
+25.65%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
-$17.2M
Cap. Flow
-$76.5M
Cap. Flow %
-33.21%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$75.6M
2
ATVI
Activision Blizzard
ATVI
+$874K

Sector Composition

Rank Sector Weight
1 Healthcare 99.54%
2 Technology 0.4%
3 Miscellaneous 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$2.1B
$154M 66.67%
14,443,681
– –
AKRO
2
DELISTED
Akero Therapeutics
AKRO
$75.7M 32.88%
1,621,829
-1,650,000
-50% -$75.6M
ATVI
3
DELISTED
Activision Blizzard
ATVI
$910K 0.4%
10,800
-10,800
-50% -$874K
XBI icon
4
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$140K 0.06%
1,686
– –

Similar funds

ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
E
EnerVest Houston, Texas $50.1M AUM 2.25% 1-Year Est. Return
RPM
Ridgemont Partners Management Charlotte, North Carolina $49.7M AUM 26.51% 1-Year Est. Return
ECT
Ebor Charitable Trust Jackson, Wyoming $49.4M AUM 13.04% 1-Year Est. Return

Skorpios Trust's Q2 2023 Portfolio in Review

As of Q2 2023, Skorpios Trust held 4 positions worth $230M, down 6.9% from $247M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Skorpios Trust withdrew a net $76.5M in Q2 2023, reducing 2 holdings. Its largest reduction was Akero Therapeutics, cutting an estimated $75.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Technology and Miscellaneous.

  • Skorpios Trust's biggest Q2 2023 reduction was Akero Therapeutics, cutting an estimated $75.6M.
  • Skorpios Trust's ten largest holdings make up 100% of its $230M portfolio in Q2 2023.
  • Skorpios Trust opened 0 new positions and closed 0 in Q2 2023.
  • Skorpios Trust's portfolio value fell 6.9% quarter-over-quarter to $230M.

Based on Skorpios Trust's 13F filing for Q2 2023, filed 3 Aug 2023.